-1h 30m
Biophytis unveils Phase 3 Sarcopenia Trial Strategy with BIO101 in Europe and Asia (Form 6-K)
-4h 23m
-12h 27m
-14h 14m
Biophytis unveils Phase 3 Sarcopenia Trial Strategy with BIO101 in Europe and Asia
-14h 14m
-14h 21m
-14h 21m
Biophytis obtains EMA authorization to launch its Phase 2 clinical trial in obesity (Form 6-K)
9/3
Biophytis obtains EMA authorization to launch its Phase 2 clinical trial in obesity
9/2
9/2